Viz.ai IPO
Viz.ai develops AI-powered software that helps detect strokes and other critical conditions in medical imaging, enabling faster treatment decisions. The company's FDA-approved platform is used by hospitals to identify time-sensitive conditions and coordinate care teams. Investors are drawn to its life-saving technology and the large market opportunity in medical AI.
What We Know
Viz.ai has not announced any IPO plans and remains privately held. The company has raised substantial venture funding, including a Series D round that reportedly valued the company at over $1 billion, achieving unicorn status. While Viz.ai's growth in the medical AI space and unicorn valuation could position it for an eventual IPO, no concrete plans or timeline have been announced. The company appears focused on expanding its AI platform and healthcare partnerships rather than pursuing public markets in the near term.
Frequently Asked Questions
Has Viz.ai had an IPO?
No, Viz.ai has not had an IPO and is still a private company. The company has not made any announcements regarding plans to go public.
When is the Viz.ai IPO date?
Viz.ai has not announced an IPO date or timeline for going public. There are currently no confirmed details about when an IPO might occur. Sign up for alerts to stay informed.
How can I buy Viz.ai stock?
Viz.ai stock cannot be purchased publicly as the company remains private. Shares are only available to qualified investors through private investment rounds. Sign up for alerts to stay informed.
Stay Updated on the Viz.ai IPO
Get real-time alerts when Viz.ai files for an IPO, prices shares, or begins trading.
Get IPO Alerts